. Author manuscript; available in PMC: 2013 Apr 24.

Published in final edited form as: Transplantation. 2011 Jun 27;91(12):1386–1391. doi: 10.1097/TP.0b013e31821bf157

TABLE 3.

Multivariate analysis of the risk for recurrent GN according to steroid use (n=459)

Predictor	Hazard ratio (95% CI)	P
Living donor	1.44 (0.70–2.94)	0.31
African American	1.59 (0.54–4.69)	0.39
Female	1.08 (0.56–2.12)	0.79
Preemptive transplant	2.58 (1.00–6.65)	0.04
Sirolimus use	0.27 (0.08–0.89)	0.036
Rapid discontinuation of steroids^a	4.86 (2.34–10.07)	<0.0001
IgA nephropathy vs. other	11.02 (1.36–88.91)	0.02
FSGS vs. other	34.72 (4.6–261.8)	0.0006
MPGN vs. other	23.03 (2.82–188.04)	0.003
Membranous nephropathy vs. other	25.35 (2.78–230.86)	0.004

Reference group: recipients with GN on steroids and transplanted between 1994 and 1999.

GN, glomerulonephritis; FSGS, focal segmental glomerulosclerosis; MPGN, membranoproliferative glomerulonephritis; CI, confidence interval.